Credo Technology Reports Q1 Results: Should Investors Hold or Fold?

Credo (CRDO) reported Q1 FY2027 revenue of $479M (+10% sequentially, +115% YoY) and EPS of $1.20 (+130.8% YoY), beating consensus by 0.7%–2.6%, but shares fell ~10% pre-market as investors focused on the execution risk of a sharp optical ramp. Management maintained an aggressive outlook, expecting Q2 revenue of $525M–$535M and FY2027 growth of >85% YoY, but customer concentration (4 customers ~84% of revenue) and a premium valuation (forward P/E 30.09X vs sector 13.31X) leave limited room for error.

Analysis

The market is pricing the next 2-3 quarters, not the print. CRDO’s model is now in the dangerous zone where execution on a narrow set of customer programs matters more than top-line momentum; that usually compresses multiples even when fundamentals improve. In AI infrastructure, the bargaining power sits with hyperscalers once a vendor becomes “strategic,” so the more CRDO proves it matters, the more it risks tougher pricing and multi-sourcing over time.

Second-order read-through: this is less a demand warning for AI networking than a quality-of-earnings warning for the sub-sector. Broadcom is better insulated because its AI exposure is embedded in a broader, more monetizable platform; MRVL and ALAB still get the beta, but they also inherit the market’s growing skepticism that every “next leg” of connectivity growth arrives on schedule. If optical ramps slip even one quarter, the de-rating can be sharp because the stock is already discounting a smooth transition from AEC/retimers into optics.

Contrarian angle: the consensus is probably underestimating how quickly enthusiasm can flip from “AI supply-chain winner” to “customer-concentration story.” The thesis is not that AI capex breaks; it’s that incremental upside is becoming harder to monetize at 30x earnings unless the optical mix becomes visible in hard numbers. Watch the next guide, customer additions, and any change in revenue concentration—those are the falsifiers. If the company delivers two clean quarters with optical contribution inflecting, the selloff is likely overdone; absent that, the stock can keep de-rating for months even if revenues keep growing.

Key Decisions for Investors

• Short CRDO on strength over the next 1-3 weeks or express it via put spreads; the setup is a classic multiple-risk trade where even a small execution miss can re-rate the stock toward the sector.
• Pair trade: long AVGO / short CRDO for 1-3 months. AVGO offers comparable AI participation with materially lower customer-concentration and product-specific execution risk, making it the cleaner relative-value exposure.
• Treat ALAB and MRVL as sympathy-risk names rather than outright shorts today; if CRDO continues to trade poorly after the open, use that as a de-rating signal to trim high-multiple networking exposure across the basket.
• Set a watch item for the next quarter: if CRDO does not show visible optical mix expansion and customer concentration stays elevated, extend the short thesis; if optical revenue meaningfully inflects, cover.